New Haven Pharmaceuticals,

New Haven Pharmaceuticals unites industry-leading experience with data-driven insight. By applying contemporary metadata analysis to large volumes of medical information, New Haven Pharmaceuticals is able to create new solutions and significant health benefits while leveraging knowledge gleaned from decades of clinical knowledge about highly regarded drugs. By combining this evolutionary approach to drug development with its state-of-the-art technology platforms, the Company creates economies of scale and rapid development processes that are highly valued in today's managed care environment. These efficiencies will become increasingly important as Accountable Care Organizations (ACOs) help physicians, hospitals and patients move away from a volume-based reimbursement system and toward a value-based system focused on meeting appropriate medical goals for each patient. Most importantly, the Company's innovative approach—emphasizing collaboration and problem-solving—means that New Haven Pharmaceuticals can develop drugs quickly and safely so that physicians can prescribe new therapies to patients who need relief as soon as possible.